EuBiologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	455,526	443,892	418,137	324,359	1,271,414	655,399
Market Cap Growth	-24.02%	6.16%	28.91%	-74.49%	93.99%	-
Enterprise Value	-	440,624	418,132	320,550	1,239,111	-
Last Close Price	12430.00	12150.00	11470.00	8900.00	35050.00	21300.00
PE Ratio	18.32	17.85	-	-	-	-
PS Ratio	4.74	4.62	6.03	5.85	32.28	23.01
PB Ratio	-	-	3.99	2.72	10.84	6.77
P/TBV Ratio	-	-	3.88	2.66	10.75	6.87
P/FCF Ratio	-	-	21.43	-	-	-
P/OCF Ratio	-	-	15.81	50.37	-	395.02
EV/Sales Ratio	-	4.59	6.03	5.78	31.46	-
EV/EBITDA Ratio	-	-	24.79	77.93	-	-
EV/EBIT Ratio	-	12.84	54.31	-	-	-
EV/FCF Ratio	-	-	21.43	-	-	-
Debt / Equity Ratio	-	-	0.14	0.13	0.13	0.23
Debt / EBITDA Ratio	-	-	0.88	3.81	-	-
Debt / FCF Ratio	-	-	0.76	-	-	-
Asset Turnover	-	-	0.44	0.36	0.26	-
Inventory Turnover	-	-	2.26	1.95	2.01	-
Quick Ratio	-	-	0.78	0.59	1.99	1.65
Current Ratio	-	-	1.63	1.67	3.11	2.03
Return on Equity (ROE)	-	-	-13.70%	-2.90%	-26.17%	-
Return on Assets (ROA)	-	-	3.07%	-1.51%	-2.95%	-
Return on Capital (ROIC)	-	-	3.78%	-1.76%	-3.58%	-
Return on Capital Employed (ROCE)	-	-	6.10%	-2.70%	-5.40%	-4.90%
Earnings Yield	5.46%	5.60%	-3.32%	-0.34%	-2.17%	-9.18%
FCF Yield	-	-	4.67%	-0.81%	-1.12%	-0.97%
Buyback Yield / Dilution	-	-	-0.13%	-2.68%	-26.53%	-

Updated Mar 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.